Circadian Technologies Limited

Circadian Technologies Limited (ASX: CIR) was listed on the Australian Stock Exchange in 1985 and provides management and funding for the development and commercialisation of Australian biomedical research.It aims to identify high potential investment opportunities from within Australian universities and research institutes, focussing on projects which have the potential to address large markets or significant unmet medical needs. Circadian is able to provide funds for further development in addition to providing the management expertise that is essential if the project is to meet its goal of commercialisation.
Circadian has shareholdings in Optiscan Imaging Limited, Metabolic Pharmaceuticals Limited and Antisense Therapeutics Limited, companies in which Circadian has been involved in providing funding and assistance in their listing. Circadian is also the largest shareholder in Zenyth Therapeutics Limited (formerly Amrad Corporation) and a significant shareholder in Avexa Limited, both Australian pharmaceutical research companies.

Contact Details: Level 1, 10 Wallace Avenue Toorak Victoria 3142 Australia Tel: 61 3 9826 0399 Fax: 61 3 9824 0083 Email: webmaster2@circadian.com.au WWW: www.circadian.com.au/

Recent Publications by Circadian Technologies Limited:
Improving health, safety, and profits in extended hours operations (shiftwork). Circadian Technologies, Inc. (CIRCADIAN) is an international consulting...	20th April, 2005	Circadian Technologies, 24 Hartwell Avenue, Lexington, MA 02421, USA.	Ind Health. 2005 Jan;43(1):201-8.
Circadian alertness simulator for fatigue risk assessment in transportation: application to reduce frequency and severity of truck accidents. The Circadian Alertness Simulator (CAS) was developed as a practical tool...	21st July, 2004	Circadian Technologies, Inc., Lexington, MA 02421, USA.	Aviat Space Environ Med. 2004 Mar;75(3 Suppl):A107-18.
A lifestyle how-to for night-shift nurses. Lifestyle training teaches night-shift nurses the factors that impact...	22nd May, 2004	Circadian Technologies, Inc., Cambridge, Mass., USA.	Nurs Manage. 2000 Sep;31(9):28.

BioNews Results for Circadian Technologies Limited:
Circadian Technologies CEO Robert Klupacs tells AGM: "significant upside"	Proactive Investors.co.uk:  Nov 19 2009 2:18AM Matching: circadian technologies
Circadian Technologies CEO Robert Klupacs to present at Merriam Curhan Ford Investor Summit in New York	Proactive Investors.co.uk:  Nov 10 2009 6:32PM Matching: circadian technologies
Circadian Technologies CEO Robert Klupacs to present at Merriam Curhan Ford Investor Summit in NYC	Proactive Investors.co.uk:  Nov 10 2009 12:27PM Matching: circadian technologies
Circadian Technologies Limited (CIR.AX) Achieves Key Manufacturing Milestone For Cancer Drug Candidate	BioSpace:  Oct 14 2009 5:45AM Matching: circadian technologies

Circadian Technologies Limited Patents:
US Patent No.	Title
6511424	Method of and apparatus for evaluation and mitigation of microsleep events
6070098	Method of and apparatus for evaluation and mitigation of microsleep events

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 534 times since April 2007, the link to the organisation's website has been followed 78 times

Recent Search Terms used to find this page: Circadian limited | Circadian Technologies Limited | circadian alertness | Circadian Technologies | circadian consulting | circadian technologies list ASX 1985 | Circadian Technologies | circadian technologies | Circadian Technologies Limited | circadian biotechnology | .

Search for more companies in Toorak

Search for more companies in Victoria

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Circadian Technologies Limited